Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age

Phase 3

Completed

Conditions: Meningococcal Vaccine

Interventions: Biological: MenABCWY
Biological: Trumenba
Biological: Saline
Biological: MenACWY-CRM

First Posted Date: 2020-06-19

Last Posted Date: 2023-04-18

Lead Sponsor: Pfizer

Target Recruit Count: 2431

Registration Number: NCT04440163

Locations: 🇺🇸
Alabama Clinical Therapeutics, LLC, Birmington Pediatric Assocaites, Birmingham, Alabama, United States
🇺🇸
Central Research Associates, Inc., Birmingham, Alabama, United States
🇺🇸
Fiel Family and Sports Medicine, PC/CCT Research, Tempe, Arizona, United States

and more 70 locations

A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

Phase 2

Completed

Conditions: Meningococcal Vaccine

Interventions: Biological: MenABCWY
Biological: Saline

First Posted Date: 2020-06-19

Last Posted Date: 2025-01-08

Lead Sponsor: Pfizer

Target Recruit Count: 309

Registration Number: NCT04440176

Locations: 🇺🇸
Alliance for Multispecialty Research, LLC, South Jordan, Utah, United States
🇺🇸
California Research Foundation, San Diego, California, United States
🇺🇸
Nona Pediatric Center, Orlando, Florida, United States

and more 13 locations

Treatment Resistance Following Anti-cancer Therapies

Not Applicable

Terminated

Conditions: Disease Progression

Interventions: Procedure: De novo tumor tissue biopsy
Procedure: Research blood draws

First Posted Date: 2020-06-17

Last Posted Date: 2024-12-03

Lead Sponsor: Pfizer

Target Recruit Count: 38

Registration Number: NCT04436120

Locations: 🇺🇸
Southern Cancer Center, P.C., Daphne, Alabama, United States
🇺🇸
Southern Cancer Center, PC, Mobile, Alabama, United States
🇺🇸
Alaska Urological Institute dba Alaska Clinical Research Center, Anchorage, Alaska, United States

and more 26 locations

Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

Completed

Conditions: Atrial Fibrillation

First Posted Date: 2020-06-17

Last Posted Date: 2023-02-08

Lead Sponsor: Pfizer

Target Recruit Count: 109

Registration Number: NCT04435769

Locations: 🇨🇿
Fakultní nemocnice Motol, Praha 5, Czechia

Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

Completed

Conditions: Arthritis, Rheumatoid

Interventions: Drug: Enbrel

First Posted Date: 2020-06-11

Last Posted Date: 2021-09-09

Lead Sponsor: Pfizer

Target Recruit Count: 1493

Registration Number: NCT04428424

Locations: 🇮🇶
Pfizer, Baghdad, Iraq

Global Prevalence of ATTR-CM in Participants With HFpEF

Not Applicable

Terminated

Conditions: Heart Failure With Preserved Ejection Fraction
Transthyretin Amyloid Cardiomyopathy

Interventions: Diagnostic Test: Scintigraphy

First Posted Date: 2020-06-11

Last Posted Date: 2024-07-19

Lead Sponsor: Pfizer

Target Recruit Count: 347

Registration Number: NCT04424914

Locations: 🇺🇸
Eastern shore Research Institute LLC, Fairhope, Alabama, United States
🇺🇸
Heart Center Research, LLC, Huntsville, Alabama, United States
🇺🇸
Advance Medical Research Center, Miami, Florida, United States

and more 47 locations

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

Completed

Conditions: Plaque Psoriasis

Interventions: Drug: Enbrel

First Posted Date: 2020-06-11

Last Posted Date: 2021-10-25

Lead Sponsor: Pfizer

Target Recruit Count: 486

Registration Number: NCT04428411

Locations: 🇮🇶
Pfizer, Baghdad, Iraq

Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)

Completed

Conditions: Psoriatic Arthritis

Interventions: Drug: Enbrel

First Posted Date: 2020-06-11

Last Posted Date: 2021-09-14

Lead Sponsor: Pfizer

Target Recruit Count: 127

Registration Number: NCT04428502

Locations: 🇮🇶
Pfizer, Baghdad, Iraq

Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-06835919
Drug: Placebo

First Posted Date: 2020-06-11

Last Posted Date: 2022-07-21

Lead Sponsor: Pfizer

Target Recruit Count: 8

Registration Number: NCT04427917

Locations: 🇧🇪
Brussels Clinical Research Unit, Brussels, Bruxelles-capitale, Région DE, Belgium

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

Phase 3

Completed

Conditions: Respiratory Tract Infection

Interventions: Biological: RSVpreF
Biological: Placebo

First Posted Date: 2020-06-09

Last Posted Date: 2025-02-11

Lead Sponsor: Pfizer

Target Recruit Count: 14727

Registration Number: NCT04424316

Locations: 🇺🇸
Central Research Associates, Inc., Birmingham, Alabama, United States
🇺🇸
Endocrinology and Internal Medicine Associates, PC, Birmingham, Alabama, United States
🇺🇸
OB/GYN Associates of Alabama, PC, Birmingham, Alabama, United States

and more 433 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy